Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk obtains license option for Islet Neogenesis Therapy

Nov. 12, 2003

Milestone reached in osteoporosis collaboration between Celltech and Amgen

Nov. 12, 2003

Recent patent covers new liver X receptor agonists discovered by GSK scientists

Nov. 12, 2003

Novel glucocorticoid receptor modulators identified at Boehringer Ingelheim

Nov. 12, 2003

AR-10A exhibits a suitable profile for further development as an antiobesity agent

Nov. 11, 2003

Phase I trial commences for Oxycyte

Nov. 11, 2003

Enrollment under way for phase IIb obesity study of AOD-9604

Nov. 11, 2003

CAP delivery system extends duration of insulin action in preclinical study

Nov. 11, 2003

Banyu team identifies new glucokinase activators

Nov. 11, 2003

Good cardiovascular safety profile described for ospemifene in postmenopausal women

Nov. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...